Paul Schimmel
E524754
Paul Schimmel is an American biochemist and biotechnology entrepreneur known for his pioneering work on aminoacyl-tRNA synthetases and for co-founding multiple biotech companies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Paul Schimmel canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4492401 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Paul Schimmel Context triple: [Alnylam Pharmaceuticals, foundedBy, Paul Schimmel]
-
A.
Philip Steuer
Philip Steuer is a film producer best known for his work on major studio projects, including the Disney drama "Saving Mr. Banks."
-
B.
Robert Ochsenfeld
Robert Ochsenfeld was a German physicist best known for co-discovering the Meissner effect, a fundamental phenomenon in superconductivity.
-
C.
Daniel Fuchs
Daniel Fuchs was an American novelist and screenwriter known for his Brooklyn-set fiction and acclaimed Hollywood screenplays, including several classic film noirs.
-
D.
Marten Wassmann
Marten Wassmann is an architect known for his partnership role at the Dutch architecture firm Benthem Crouwel Architekten.
-
E.
Walter Meierjohann
Walter Meierjohann is a theatre director known for his innovative, visually driven productions and leadership roles in European and UK theatre institutions.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Paul Schimmel Target entity description: Paul Schimmel is an American biochemist and biotechnology entrepreneur known for his pioneering work on aminoacyl-tRNA synthetases and for co-founding multiple biotech companies.
-
A.
Philip Steuer
Philip Steuer is a film producer best known for his work on major studio projects, including the Disney drama "Saving Mr. Banks."
-
B.
Robert Ochsenfeld
Robert Ochsenfeld was a German physicist best known for co-discovering the Meissner effect, a fundamental phenomenon in superconductivity.
-
C.
Daniel Fuchs
Daniel Fuchs was an American novelist and screenwriter known for his Brooklyn-set fiction and acclaimed Hollywood screenplays, including several classic film noirs.
-
D.
Marten Wassmann
Marten Wassmann is an architect known for his partnership role at the Dutch architecture firm Benthem Crouwel Architekten.
-
E.
Walter Meierjohann
Walter Meierjohann is a theatre director known for his innovative, visually driven productions and leadership roles in European and UK theatre institutions.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
academic
ⓘ
biochemist ⓘ biotechnology entrepreneur ⓘ |
| academicDegree |
Bachelor of Arts in chemistry
ⓘ
PhD in biophysical chemistry ⓘ |
| coFounded |
Alkermes
NERFINISHED
ⓘ
Alnylam Pharmaceuticals NERFINISHED ⓘ Cubist Pharmaceuticals NERFINISHED ⓘ Repligen NERFINISHED ⓘ Schrodinger, Inc. NERFINISHED ⓘ Sirtris Pharmaceuticals NERFINISHED ⓘ aTyr Pharma NERFINISHED ⓘ |
| countryOfCitizenship | United States of America ⓘ |
| educatedAt |
Massachusetts Institute of Technology
ⓘ
Ohio Wesleyan University NERFINISHED ⓘ |
| employer |
Massachusetts Institute of Technology
ⓘ
The Scripps Research Institute NERFINISHED ⓘ |
| fieldOfWork |
RNA biology
ⓘ
biochemistry ⓘ molecular biology ⓘ structural biology ⓘ |
| hasPublishedOn |
disease associations of tRNA synthetases
ⓘ
editing functions in tRNA aminoacylation ⓘ structure–function relationships of aminoacyl-tRNA synthetases ⓘ |
| hasReceivedAward |
American Chemical Society Pfizer Award in Enzyme Chemistry
NERFINISHED
ⓘ
American Chemical Society Ralph F. Hirschmann Award in Peptide Chemistry NERFINISHED ⓘ Biophysical Society Founders Award NERFINISHED ⓘ National Institutes of Health MERIT Award NERFINISHED ⓘ |
| hasWritten |
scientific articles on aminoacyl-tRNA synthetases
ⓘ
textbooks on biophysical chemistry ⓘ |
| knownFor |
linking tRNA synthetase biology to human disease
ⓘ
translating basic RNA biology into therapeutics ⓘ |
| languageOfWorkOrName | English ⓘ |
| memberOf |
American Academy of Arts and Sciences
ⓘ
American Philosophical Society ⓘ National Academy of Sciences ⓘ
surface form:
National Academy of Sciences of the United States of America
|
| notableFor |
biotechnology company founding
ⓘ
pioneering work on the genetic code ⓘ research on aminoacyl-tRNA synthetases ⓘ |
| occupation |
biochemist
ⓘ
biotechnology entrepreneur ⓘ professor ⓘ |
| positionHeld |
Ernest and Jean Hahn Professor at The Scripps Research Institute
NERFINISHED
ⓘ
Professor of Biochemistry at MIT ⓘ |
| researchFocus |
aminoacyl-tRNA synthetases
ⓘ
mechanisms of protein synthesis ⓘ noncanonical functions of tRNA synthetases ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Paul Schimmel Description of subject: Paul Schimmel is an American biochemist and biotechnology entrepreneur known for his pioneering work on aminoacyl-tRNA synthetases and for co-founding multiple biotech companies.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.